Ability to Perform Daily Physical Activities in Individuals with Type 2 Diabetes and Moderate Obesity: a Preliminary Validation of the Impact of Weight on Activities of Daily Living Questionnaire
Overview
Pharmacology
Affiliations
Background: The aims of this study were (1) to demonstrate the reliability and validity of the Impact of Weight on Activities of Daily Living Questionnaire (IWADL), a measure of ability to perform daily physical activities, in individuals with type 2 diabetes who are moderately obese and (2) to characterize those individuals with low self-reported ability.
Methods: Data from a web-based survey of individuals with type 2 diabetes and body mass index (BMI) of 30-40 k/mg(2) were used to calculate Cronbach's α and demonstrate both IWADL factorial and construct validity. These data were entered into a multivariable multinomial logistic regression model with survey variables (demographics, health status, weight- and diabetes-related) as the independent variables and three IWADL scoring groups (Low, Medium, and High) as the dependent variables.
Results: Study participants were 349 individuals with type 2 diabetes (mean age = 59 years, 44% male, 91% white, mean BMI = 35 k/mg(2)). Factor analysis indicated a one-factor solution for a seven-item IWADL with Cronbach's α = 0.94. Significant (P < 0.05) relationships were identified between IWADL and variables previously shown to be related to level of physical activity. Ten variables remained independently (P < 0.05) related to IWADL scores, including age, gender, health status, current exercise, using exercise programs or hypnosis as a step to lose weight, and self-reported weight history.
Conclusions: The IWADL is a reliable and valid measure of the ability of individuals with type 2 diabetes and moderate obesity to perform daily physical activities. This ability may be an important patient-reported end point to include in clinical trials of antihyperglycemic medications that produce weight loss.
Boye K, Sapin H, Dong W, Williamson S, Lee C, Thieu V Diabetes Ther. 2023; 14(11):1867-1887.
PMID: 37668888 PMC: 10570229. DOI: 10.1007/s13300-023-01457-7.
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.
Terwee C, Elders P, Blom M, Beulens J, Rolandsson O, Rogge A Diabetologia. 2023; 66(8):1357-1377.
PMID: 37222772 PMC: 10317894. DOI: 10.1007/s00125-023-05926-3.
Terwee C, Elders P, Langendoen-Gort M, Elsman E, Prinsen C, van der Heijden A Curr Diab Rep. 2022; 22(9):405-421.
PMID: 35819705 PMC: 9355936. DOI: 10.1007/s11892-022-01482-z.
Langendoen-Gort M, Groeneveld L, Prinsen C, Beulens J, Elders P, Halperin I Rev Endocr Metab Disord. 2022; 23(5):931-977.
PMID: 35779199 PMC: 9515038. DOI: 10.1007/s11154-022-09734-9.
Elsman E, Mokkink L, Langendoen-Gort M, Rutters F, Beulens J, Elders P BMJ Open Diabetes Res Care. 2022; 10(3).
PMID: 35675952 PMC: 9185403. DOI: 10.1136/bmjdrc-2021-002729.